Scott Baum

1.2k total citations
17 papers, 327 citations indexed

About

Scott Baum is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Scott Baum has authored 17 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Scott Baum's work include Virus-based gene therapy research (3 papers), Cancer Research and Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Scott Baum is often cited by papers focused on Virus-based gene therapy research (3 papers), Cancer Research and Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Scott Baum collaborates with scholars based in United States, United Kingdom and Italy. Scott Baum's co-authors include EUGENE C. MANGIANTE, Kenneth A. Kudsk, Timothy C. Fabian, R. E. Gold, Guy Voeller, Thomas F. Boulden, Ina L.D. Tonkin, Martin A. Croce, L Britt and Morris L. Gavant and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The American Journal of Surgery.

In The Last Decade

Scott Baum

16 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Baum United States 8 141 125 108 74 53 17 327
Maria Sofia Rosati Italy 8 199 1.4× 117 0.9× 34 0.3× 63 0.9× 81 1.5× 24 346
Kaufman Sl United States 12 459 3.3× 436 3.5× 63 0.6× 12 0.2× 53 1.0× 25 593
Surbhi Shah United States 10 44 0.3× 41 0.3× 160 1.5× 13 0.2× 52 1.0× 44 382
Chiara Ambaglio Italy 12 47 0.3× 65 0.5× 131 1.2× 9 0.1× 39 0.7× 21 415
Karine Juvin France 10 112 0.8× 156 1.2× 87 0.8× 12 0.2× 29 0.5× 21 332
Shoki Mikata Japan 13 275 2.0× 188 1.5× 7 0.1× 25 0.3× 46 0.9× 48 465
Allyson M. Pishko United States 13 197 1.4× 28 0.2× 128 1.2× 93 1.3× 36 0.7× 34 427
J. J. Michiels Netherlands 14 111 0.8× 39 0.3× 168 1.6× 33 0.4× 15 0.3× 27 475
M. Beckers Netherlands 10 62 0.4× 47 0.4× 184 1.7× 6 0.1× 75 1.4× 21 424
Bernt Ly Norway 9 215 1.5× 107 0.9× 319 3.0× 12 0.2× 13 0.2× 32 497

Countries citing papers authored by Scott Baum

Since Specialization
Citations

This map shows the geographic impact of Scott Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Baum more than expected).

Fields of papers citing papers by Scott Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Baum. The network helps show where Scott Baum may publish in the future.

Co-authorship network of co-authors of Scott Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Baum. A scholar is included among the top collaborators of Scott Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Baum. Scott Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Baum, Scott. (2023). Exploring Disparities in Breast Cancer Screening: An Ecological Analysis of Australian Data. Asian Pacific Journal of Cancer Prevention. 24(12). 4139–4145.
2.
Baum, Scott, et al.. (2021). Radiofrequency ablation for the treatment of recurrent gynecological malignancies. Gynecologic Oncology. 162. S254–S255. 1 indexed citations
3.
Aroldi, Francesca, Mark R. Middleton, Joseph J. Sacco, et al.. (2021). 1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]. Annals of Oncology. 32. S903–S904. 2 indexed citations
4.
Middleton, Mark R., Francesca Aroldi, Joseph J. Sacco, et al.. (2020). An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts.. Journal of Clinical Oncology. 38(15_suppl). e22050–e22050. 16 indexed citations
5.
Middleton, Mark R., Joseph J. Sacco, Jaime R. Merchan, et al.. (2019). Initial results of the phase 1 portion of an ongoing phase 1/2 study of RP1 as a single agent and in combination with nivolumab in patients with solid tumors. Journal for ImmunoTherapy of Cancer. 7. 1 indexed citations
6.
Middleton, Mark R., Joseph J. Sacco, Jaime R. Merchan, et al.. (2019). An open label, multicenter, phase I/II study of RP1 as a single agent and in combination with PD1 blockade in patients with solid tumors.. Journal of Clinical Oncology. 37(15_suppl). TPS2671–TPS2671. 3 indexed citations
7.
Powell, Daniel K. & Scott Baum. (2018). Bronchopleural Fistula Treated with N-Butyl Cyanoacrylate Glue after Ablation. Journal of Vascular and Interventional Radiology. 29(12). 1692–1693. 8 indexed citations
8.
Friedrich, M., et al.. (2017). Breast cancer and metastases of the central nervous system. European Journal of Gynaecological Oncology. 38(5). 653–656. 1 indexed citations
9.
Yaghmour, George, Manjari Pandey, Kruti Patel, et al.. (2016). Role of genomic instability in immunotherapy with checkpoint inhibitors.. Journal of Clinical Oncology. 34(15_suppl). 3052–3052. 15 indexed citations
10.
Yaghmour, George, Manjari Pandey, Kruti Patel, et al.. (2016). Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.. PubMed. 36(8). 4033–8. 26 indexed citations
11.
Matsell, Douglas G., Deborah P. Jones, Thomas F. Boulden, et al.. (1992). Arteriovenous fistula after biopsy of renal transplant kidney: diagnosis and treatment. Pediatric Nephrology. 6(6). 562–564. 24 indexed citations
12.
Tonkin, Ina L.D., Aram S. Hanissian, Thomas F. Boulden, et al.. (1991). Bronchial arteriography and embolotherapy for hemoptysis in patients with cystic fibrosis. CardioVascular and Interventional Radiology. 14(4). 241–246. 48 indexed citations
13.
Gold, R. E., et al.. (1991). Trauma center imaging problems: Proposed solution with picture archiving communication systems. Journal of Digital Imaging. 4(2). 79–86. 4 indexed citations
14.
Croce, Martin A., Timothy C. Fabian, Kenneth A. Kudsk, et al.. (1991). AAST Organ Injury Scale. The Journal of Trauma: Injury, Infection, and Critical Care. 31(6). 806–812. 50 indexed citations
15.
Gavant, Morris L., et al.. (1990). Initial experience with a universal-length copolymer ureteral stent. CardioVascular and Interventional Radiology. 13(2). 98–101. 2 indexed citations
16.
Kudsk, Kenneth A., Timothy C. Fabian, Scott Baum, et al.. (1989). Silent deep vein thrombosis in immobilized multiple trauma patients. The American Journal of Surgery. 158(6). 515–519. 124 indexed citations
17.
Ring, EJ, et al.. (1974). Angiography in the diagnosis and treatment of nonvariceal bleeding in patients with portal hypertension.. PubMed. 139(2). 205–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026